InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.39
(
0.00%
)
US TECH 100
18,055.60
(
0.22%
)
Dow Jones
39,357.01
(
-0.36%
)
Brent Oil
81.43
(
-0.22%
)
Bitcoin
59,409.57
(
0.08%
)
Post# of 14825
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bloodhound99

Send PM Follow Ignore
Followers 8
Posts 6947
Boards Moderated 0
Alias Born 07/31/2006

bloodhound99

Re: Scheilko post# 3427

Saturday, 05/05/2007 10:02:05 AM

Saturday, May 05, 2007 10:02:05 AM

Post# of 14825
a Bit of Good news. The article says that rapid tests will be the key with possible opt-out provision. Gee I started advocating that 4 years ago. Nice to see CDC affirming my position.

Of the 30 companies whose names were mentioned I wonder how many are like Calypte in that they have no FDA approved HIV 1/2 rapid tests to sell in US and have not filed an IDE to begin the process.

Now Roger its time to drive up to Seattle, just a few hundred kilometers North of you, and visit with Bill and Melinda Gates.

Whatever happened to management's statement that Calypte was looking for a new larger home office and manufacturing plant combo in Oregon area anyway?



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up